Home > Insider Trading > Onyx Pharmaceuticals Inc

Onyx Pharmaceuticals Inc (ONXX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50
Next >>

Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?

Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN). However, after that it hired an investment banker for finding a suitable buyer.

Keep Reading →

July 10th, 2013 - News

Who Is the Best Suitor for Onyx Pharmaceuticals, Inc. (ONXX)?

Cancer-drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) recently rejected an $8.7 billion unsolicited acquisition offer from Amgen, Inc. (NASDAQ:AMGN).

Keep Reading →

July 10th, 2013 - News

Onyx Pharmaceuticals, Inc. (ONXX), Pharmacyclics, Inc. (PCYC): Will This Biotech Acquisition Buzz Lead to More Buyouts?

The analysts, bloggers, and columnists were out in full force last Monday morning to assess the true “worth” of Onyx.

Keep Reading →

July 9th, 2013 - News

Amgen, Inc. (AMGN) Stirs the Pot in the Cancer-Related Sector

Several companies are fighting to be the first to release a treatment or cure for cancer that is a game-changer, and this battle has created a field where firms are looking to take any competitive advantage...

Keep Reading →

July 8th, 2013 - News

Onyx Pharmaceuticals, Inc. (ONXX), Achillion Pharmaceuticals, Inc. (ACHN): This Week in Biotech

With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

July 8th, 2013 - News

Onyx Pharmaceuticals, Inc. (ONXX), Celldex Therapeutics, Inc. (CLDX): Three Humongous Health-Care Stocks This Week

While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs.

Keep Reading →

July 8th, 2013 - News

How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?

The promising cancer developer confirmed over the weekend that Amgen had made an offer to acquire Onyx for $120 per share, a 38.2% premium above Friday's close. Onyx Pharmaceuticals, Inc.

Keep Reading →

July 5th, 2013 - News

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Is This Biopharmaceutical Stock Still a Buy?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) has recently experienced a significant jump of nearly 51.3% in only one trading day from $86.82 per share to $131.30 per share.

Keep Reading →

July 5th, 2013 - News